Novartis AG vs Oscar Health Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Oscar Health Inc trades at $30.76 (market cap $8.92B). The key difference: Novartis AG is far larger — about 32.5× Oscar Health Inc's market cap, and Novartis AG pays a 3.17% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| NVS | OSCR | |
|---|---|---|
Market Cap | $290.25B | $8.92B |
Sector | Health | Health |
52-Week High | $168.62 | $32.18 |
52-Week Low | $113.50 | $10.85 |
Enterprise Value | $330.27B | $4.55B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →